HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Malone Selected Research

Weight Loss (Weight Reduction)

6/2011DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Malone Research Topics

Disease

2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2003 - 12/2001
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Type 2 Diabetes Mellitus (MODY)
06/2011
1Nausea
06/2011
1Weight Loss (Weight Reduction)
06/2011
1Acute Kidney Injury (Acute Renal Failure)
08/2008
1Chronic Kidney Failure (Chronic Renal Failure)
08/2008
1Carcinogenesis
05/2002
1Ovarian Epithelial Carcinoma
05/2002
1Albuminuria
12/2001
1Cutaneous Candidiasis
11/2001
1Candidiasis (Moniliasis)
11/2001

Drug/Important Bio-Agent (IBA)

1Sitagliptin Phosphate (Januvia)FDA Link
06/2011
1Pioglitazone (Actos)FDA Link
06/2011
1Exenatide (Byetta)FDA Link
06/2011
1Glucose (Dextrose)FDA LinkGeneric
06/2011
1Metformin (Glucophage)FDA LinkGeneric
06/2011
1Glucagon-Like Peptide 1 (GLP 1)IBA
06/2011
1AutoantibodiesIBA
06/2003
1ProstaglandinsIBA
05/2002
1EnzymesIBA
05/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2002
1AlbuminsIBA
12/2001
1EpitopesIBA
11/2001
1AntibodiesIBA
11/2001

Therapy/Procedure

1Radiotherapy
01/2022
1Critical Care (Surgical Intensive Care)
08/2008
1Glycemic Control
12/2001
1Therapeutics
12/2001